The Androgen Receptor Directly Targets the Cellular Fas/FasL-Associated Death Domain Protein-Like Inhibitory Protein Gene to Promote the Androgen-Independent Growth of Prostate Cancer Cells-Reference-Cited by-同舟云学术

The Androgen Receptor Directly Targets the Cellular Fas/FasL-Associated Death Domain Protein-Like Inhibitory Protein Gene to Promote the Androgen-Independent Growth of Prostate Cancer Cells

Published:2005-07-01 Issue:7 Volume:19 Page:1792-1802
ISSN:0888-8809
Container-title:Molecular Endocrinology
language:en
Short-container-title:

Author:

Gao Shen¹,Lee Peng²,Wang Hua¹,Gerald William³,Adler Michael²,Zhang Liying³,Wang Yun-Fang¹,Wang Zhengxin¹

Affiliation:

1. Department of Cancer Biology (S.G., H.W., Y.-F.W., Z.W.), The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030;

2. Department of Pathology (P.L., M.A.), New York University School of Medicine and New York Harbor Healthcare System, New York, New York 10010;

3. Department of Pathology (W.G., L.Z.), Memorial Sloan Kettering Cancer Center, New York, New York 10021

Publisher

The Endocrine Society

Subject

Endocrinology,Molecular Biology,General Medicine

Link

http://academic.oup.com/mend/article-pdf/19/7/1792/8952912/mend1792.pdf

Reference48 articles.

1. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.;Denmeade;Prostate,1996

2. Molecular mechanisms of prostate cancer.;Porkka;Eur Urol,2004

3. The androgen receptor: a potential target for therapy of prostate cancer.;Santos;Steroids,2004

4. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.;Craft;Nat Med,1999

5. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.;Craft;Cancer Res,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TNF Signaling Is Required for Castration-Induced Vascular Damage Preceding Prostate Cancer Regression;Cancers;2022-12-07

2. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer;Cancers;2022-12-06

3. Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and stem-like cells in lethal prostate cancer;2022-07-22

4. TNF signaling is required for castration-induced vascular damage preceding prostate cancer regression;2022-02-08

5. Signaling Pathways That Control Apoptosis in Prostate Cancer;Cancers;2021-02-24